All In MedTech

Device Trial Radar · NCT02812784

Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?

Last checked: Nov 19, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

184

Actual

Start

Sep 16, 2015

Primary completion

Feb 11, 2019

Study completion Feb 11, 2019

Sponsor

Lead sponsor
Centre Hospitalier Universitaire, AmiensAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 24, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with septic shock in the intensive care unit have an elevated risk of developing acute kidney injury (AKI).

Conditions

  • Heading

Interventions

  • Nephrocheck TMDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. KDIGO classificationTime frame: 72 hours

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Amiens

    Amiens, France

  • CH Avranches-Granville

    Avranches, France

  • CH Cahors

    Cahors, France

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.